Chaemsupaphan Thanaboon, Pimolsri Chawanont, Subdee Nichcha, Phaophu Phutthaphorn, Salaemae Marianee, Permpim Parinya, Thongchot Lakkana, Wannasewok Kamonnet, Chotinaiwattarakul Wattanachai, Limsrivilai Julajak
Division of Gastroenterology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Siriraj Sleep Center, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Therap Adv Gastroenterol. 2025 Jan 3;18:17562848241311142. doi: 10.1177/17562848241311142. eCollection 2025.
The association between inflammatory bowel disease (IBD) activity and poor sleep quality is reported. However, most research subjectively investigated this issue and lacked long-term follow-up.
Our study aimed to investigate the prevalence of sleep disturbance in IBD patients across disease activity and evaluate the long-term correlation between disease activity, sleep quality, and quality of life.
This prospective observational study assessed sleep quality in patients with IBD.
Patients with IBD were categorized into groups based on clinical activity scores. The sleep questionnaire (Pittsburgh Sleep Quality Index (PSQI)) and IBD questionnaire (IBDQ) were evaluated monthly for 12 months. Seven-day sleep data from wrist actigraphy (Actiwatch) were collected at initiation and completion. Longitudinal correlation was analyzed.
A total of 98 participants were enrolled, consisting of 68 remission, 21 mild, and 9 moderate-to-severe disease activities. At baseline, 60% of participants demonstrated poor sleep quality, defined by a PSQI of >5. The group with greater disease severity reported numerically poorer sleep quality; however, this difference was not statistically significant. On actigraphy, there was no statistically significant difference in sleep latency, wake after sleep onset, or sleep efficiency between the groups. During follow-up, 90 patients responded to questionnaires. The mean PSQI decreased from 7.1 to 5.4 among 22 patients whose active disease transitioned to remission ( < 0.001). However, the score did not change in 11 patients with remission and developed disease flare (5.9-5.8). The mean PSQI was 7.7 and 6.3 in 4 and 53 patients whose disease remained active and inactive during follow-up, respectively. Multivariable longitudinal analysis revealed that PSQI was independently associated with active disease (odds ratio = 1.22) and inversely associated with IBDQ (β = -2.23). Sleep latency was evaluated by PSQI, and actigraphy was significantly correlated.
Patients with IBD frequently experience poor sleep quality, which significantly correlates with active disease and worse quality of life longitudinally.
有报道称炎症性肠病(IBD)活动与睡眠质量差之间存在关联。然而,大多数研究是主观调查此问题,且缺乏长期随访。
我们的研究旨在调查不同疾病活动状态下IBD患者睡眠障碍的患病率,并评估疾病活动、睡眠质量和生活质量之间的长期相关性。
这项前瞻性观察性研究评估了IBD患者的睡眠质量。
根据临床活动评分将IBD患者分组。睡眠问卷(匹兹堡睡眠质量指数(PSQI))和IBD问卷(IBDQ)每月评估一次,共评估12个月。在开始和结束时收集来自手腕活动记录仪(Actiwatch)的7天睡眠数据,并进行纵向相关性分析。
共纳入98名参与者,其中68名处于缓解期,21名处于轻度疾病活动期,9名处于中度至重度疾病活动期。在基线时,60%的参与者睡眠质量差,定义为PSQI>5。疾病严重程度较高的组在数值上报告的睡眠质量较差;然而,这种差异无统计学意义。在活动记录仪监测方面,各组之间在睡眠潜伏期、睡眠中觉醒时间或睡眠效率方面无统计学显著差异。在随访期间,90名患者回复了问卷。22名疾病从活动期转变为缓解期的患者,其平均PSQI从7.1降至5.4(<0.001)。然而,11名缓解期患者病情复发,其评分未改变(5.9 - 5.8)。在随访期间疾病持续活动和不活动的4名和53名患者中,平均PSQI分别为7.7和6.3。多变量纵向分析显示,PSQI与疾病活动独立相关(优势比 = 1.22),与IBDQ呈负相关(β = -2.23)。通过PSQI评估的睡眠潜伏期与活动记录仪监测结果显著相关。
IBD患者经常睡眠质量差,这与疾病活动及纵向更差的生活质量显著相关。